APA (7th ed.) Citation

Noor, N. M., Zheng, H., Robertson, D. S., Savage, J., Yap, C., Jorgensen, A. L., & Wason, J. M. S. (2025). Interpreting results from biomarker-guided clinical trials: Avoiding "negative" or "failed" terminology. BMC Medicine, 23(1), 1. https://doi.org/10.1186/s12916-025-04035-9

Chicago Style (17th ed.) Citation

Noor, Nurulamin M., Haiyan Zheng, David S. Robertson, Joshua Savage, Christina Yap, Andrea L. Jorgensen, and James M. S. Wason. "Interpreting Results from Biomarker-guided Clinical Trials: Avoiding "Negative" or "Failed" Terminology." BMC Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12916-025-04035-9.

MLA (9th ed.) Citation

Noor, Nurulamin M., et al. "Interpreting Results from Biomarker-guided Clinical Trials: Avoiding "Negative" or "Failed" Terminology." BMC Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12916-025-04035-9.